Overview Financials News + Filings Key Docs Charts Ownership Insiders |
180 Life Sciences Corp. (KBLM)
|
Add to portfolio |
|
|
Price: |
$3.90
| | Metrics |
OS: |
5.32
|
M
| |
|
|
Market cap: |
$20.7
|
M
| |
|
|
Net cash:
|
$1.39
|
M
| |
$0.26
|
per share
|
EV:
|
$19.3
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 |
Cost of goods sold | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 |
Research and development | 2.2 | 1.0 | | | | |
General and administrative | 15.5 | 11.7 | | 1.2 | 0.6 | 0.3 |
EBITA | -20.7 | -14.4 | | -1.2 | -0.6 | -0.3 |
Amortization of intangibles | 0.1 | 0.1 | | | | |
EBIT | -20.8 | -14.6 | | -1.2 | -0.6 | -0.3 |
Pre-tax income | -39.7 | -20.3 | | 0.2 | 1.5 | 0.3 |
Income taxes | -0.9 | 0.0 | | 0.3 | 0.4 | 0.2 |
Tax rate | 2.4% | 0.1% | | 155.0% | 28.4% | 61.2% |
Net income | -38.7 | -20.3 | | -0.1 | 1.0 | 0.1 |
|
Diluted EPS | ($20.38) | ($12.96) | | ($0.02) | $0.07 | $0.01 |
Shares outstanding (diluted) | 1.9 | 1.6 | | 4.2 | 14.9 | 9.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|